RS20050898A - Deramciclane-fumarate tablets - Google Patents

Deramciclane-fumarate tablets

Info

Publication number
RS20050898A
RS20050898A YUP-2005/0898A YUP20050898A RS20050898A RS 20050898 A RS20050898 A RS 20050898A YU P20050898 A YUP20050898 A YU P20050898A RS 20050898 A RS20050898 A RS 20050898A
Authority
RS
Serbia
Prior art keywords
weight
deramciclane
fumarate
tablets
fumarate tablets
Prior art date
Application number
YUP-2005/0898A
Other languages
English (en)
Inventor
Pal Fekete
Laszlone GORA
Huszar Magdolna Leventiszne
Laszlone Maroshelyi
Zsolt Zsigmond
Istvanne Jambor
Jozsef Tari
Original Assignee
Egys Gyogyszergyar Rt,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egys Gyogyszergyar Rt, filed Critical Egys Gyogyszergyar Rt,
Publication of RS20050898A publication Critical patent/RS20050898A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pronalazak se odnosi na tablete koje sadrže deramciklan-fumarat formule (I) gde pomenute tablete sadrže (u odnosu na ukupnu težinu) više od 50% težinski deramciklan-fumarata, 5-20% težinski popunjivača, 5-20% težinski mikrokristalne celuloze koja ima prosečnu veličinu čestica ispod 30μm, 1-10% težinski dezintegranta, 0.5-4% težinski lubrikanta, 0.5-4% težinski anti-athezivnog agensa i 0-30% težinski popunjivača. Deramciklan-fumarat je poznat anksiolitički aktivni sastojak.
YUP-2005/0898A 2003-06-03 2004-06-03 Deramciclane-fumarate tablets RS20050898A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301537A HUP0301537A3 (en) 2003-06-03 2003-06-03 Deramcyclane fumarate tablets and process for producing them
PCT/HU2004/000058 WO2004105743A1 (en) 2003-06-03 2004-06-03 Deramciclane-fumarate tablets

Publications (1)

Publication Number Publication Date
RS20050898A true RS20050898A (en) 2008-04-04

Family

ID=90001686

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0898A RS20050898A (en) 2003-06-03 2004-06-03 Deramciclane-fumarate tablets

Country Status (25)

Country Link
US (1) US20060258745A1 (sr)
EP (1) EP1628648B1 (sr)
JP (1) JP2006526603A (sr)
KR (1) KR20060015746A (sr)
CN (1) CN1832733A (sr)
AT (1) ATE381325T1 (sr)
AU (1) AU2004243240A1 (sr)
BG (1) BG109404A (sr)
BR (1) BRPI0410909A (sr)
CA (1) CA2527431A1 (sr)
CZ (1) CZ2005817A3 (sr)
DE (1) DE602004010803D1 (sr)
EA (1) EA009681B1 (sr)
HR (1) HRP20050979A2 (sr)
HU (1) HUP0301537A3 (sr)
IL (1) IL172133A0 (sr)
IS (1) IS8202A (sr)
MX (1) MXPA05013020A (sr)
NO (1) NO20056220L (sr)
PL (1) PL378540A1 (sr)
RS (1) RS20050898A (sr)
SK (1) SK51112005A3 (sr)
UA (1) UA80209C2 (sr)
WO (1) WO2004105743A1 (sr)
ZA (1) ZA200510139B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
CN110973635B (zh) * 2019-12-26 2022-07-29 汤臣倍健股份有限公司 一种辅料组合物及益生菌片剂
CN114643014B (zh) * 2022-05-07 2024-02-13 佛山市锦厨食品科技有限公司 一种可提高颗粒状鸡精的成型速度的食品用造粒机

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
SI20624A (sl) * 1998-12-18 2002-02-28 Abbott Laboratories Formulacija divalproeks natrija za kontrolirano sproščanje
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
UA75831C2 (en) * 2002-04-29 2006-05-15 Egyt Gyogyszervegyeszeti Gyar Process for preparation of tablets from pharmaceutically active ingredients having unfavourable tabletting properties with the use of granulating liquid containing microcrystalline cellulose

Also Published As

Publication number Publication date
IL172133A0 (en) 2006-04-10
ATE381325T1 (de) 2008-01-15
BRPI0410909A (pt) 2006-06-27
HUP0301537D0 (en) 2003-08-28
EP1628648B1 (en) 2007-12-19
CA2527431A1 (en) 2004-12-09
DE602004010803D1 (de) 2008-01-31
AU2004243240A1 (en) 2004-12-09
CN1832733A (zh) 2006-09-13
MXPA05013020A (es) 2006-03-17
CZ2005817A3 (cs) 2006-04-12
US20060258745A1 (en) 2006-11-16
SK51112005A3 (sk) 2006-06-01
BG109404A (en) 2006-11-30
HUP0301537A2 (hu) 2005-03-29
NO20056220L (no) 2006-03-02
UA80209C2 (en) 2007-08-27
PL378540A1 (pl) 2006-05-02
EA009681B1 (ru) 2008-02-28
HRP20050979A2 (en) 2006-03-31
HUP0301537A3 (en) 2005-07-28
ZA200510139B (en) 2007-03-28
EP1628648A1 (en) 2006-03-01
EA200501883A1 (ru) 2006-06-30
WO2004105743A1 (en) 2004-12-09
KR20060015746A (ko) 2006-02-20
JP2006526603A (ja) 2006-11-24
IS8202A (is) 2005-12-28

Similar Documents

Publication Publication Date Title
MX2007004294A (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion.
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
TNSN04213A1 (en) High drug load tablet
RS20080072A (en) Compositions comprising a cholesterol absorbtion inhibitor, and hmg-coa reductase inhibitor and stabilizing agent
WO2003028703A3 (en) Immediate release tablet
WO2007048219A3 (en) Sustained drug release composition
WO2008132710A3 (en) Pharmaceutical nimodipine compositions
JO2584B1 (en) Modified Release Formula 1 - ((3-Hydroxyl-Adamant-1-Ylamino) -acetyl) -perrolidine-2 (S) Carbonitrile
AU7278500A (en) Fungicides
MXPA04011914A (es) Formulacion farmaceutica de liberacion modificada.
MY163503A (en) Aerosol formulations for the inhalation of beta agonists
WO2007099548A3 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
SG131759A1 (en) Lubricating compositions for friction material interfaces
AU2003268342A8 (en) Antimicrobial compositions
EP2210888A3 (en) Stable micronized candesartan cilexetil and methods for preparing thereof
IL172133A0 (en) Deramciclane-fumarate tablets
MX2007014963A (es) Composicion de liberacion modificada de al menos una forma de venlafaxina.
SE0203070D0 (en) Novel compounds
TNSN08546A1 (en) Aminoalcohol derivative and immunosuppressive agent having same as an active ingredient
EP1734046A4 (en) radiosensitizing
AU2003286210A1 (en) Smoke composition
EP1510511A4 (en) GINGEROL ANALOGS AND THEIR USE
WO2004069228A3 (en) Sustained release formulations of venlafaxine
UA96159C2 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ b-АГОНИСТОВ
WO2008004164A3 (en) Cosmetic and/or dermatological composition combining a c-glycoside derivative and a desquamating agent